1. Novel Autoantibodies Biomarkers Panel to Prognosticate the Clinical Outcomes in Advanced-stage NSCLC Patients Receiving Anti PD-1/PD-L1 Immunotherapy. (28th October 2020) Authors: Tarhoni, I; Fhied, C; Borgia, J A; Fidler, M J; Batus, M; Bonomi, P Journal: American journal of clinical pathology Issue: Volume 154(2020)Supplement 1 Page Start: S142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗